PVLA (pieris.com) Bozor qiymatining balans qiymatiga nisbati
Dori vositalariga bo'lgan barqaror talab Pieris Pharmaceuticals (PVLA) kompaniyasini himoya qiladi, garchi geosiyosat xomashyo logistikasini buzishi mumkin bo'lsa-da. GURU.Markets platformasida aksiyalar narxidagi 8.79 miqdoridagi bozor tebranishlari aktivning dinamikasini aniq namoyish etadi. Biznes biologiya ekspertlaridan iborat ixcham shtatga tayanadi, u maxsus loyihalar uchun kengaytiriladi. O'sish onkologiyaga qarshi oqsillarning ishlab chiqilishi, cinpanemab muvaffaqiyati va sog'liqni saqlash gigantlari bilan tuzilgan ittifoqlar hisobiga ta'minlanmoqda.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_PVLA_-_Pieris-Pharmaceuticals_-_Market-Capitalization-to-Net-Assets "PVLA Pieris Corp Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Pieris Pharma (PVLA) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Pieris Pharmaceuticals|PVLA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Pieris Pharmaceuticals Inc|PVLA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Pieris Pharmaceuticals Inc|PVLA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Pieris Pharmaceuticals
Kompaniyaning dastlabki tahlili:Pieris Pharmaceuticals - PVLA
Ushbu ko'rsatkich kompaniyaning bozor qiymatining uning sof aktivlaridan yuqoriligini aks ettiradi va biznesning kitob kapitaliga nisbatan haddan tashqari qimmat yoki arzon baholanganligini baholash imkonini beradi. Bozor kapitalizatsiyasining kitob qiymatiga nisbatini tahlil qilish orqali investor Pieris Pharmaceuticals (PVLA) kompaniyasining noyob Anticalin oqsili patent portfelini bozor qanday baholashini ko'rishi mumkin, uning qiymati ulkan R&D xarajatlari va tartibga soluvchi to'siqlar bilan belgilanadi.
Asosiy raqobatchilar
ARGX: Bozor kapitallashuvining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|SVRA: Bozor kapitallashuvining balans qiymatiga nisbati|Rigel Pharma - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati AnaptysBio Corp|ATXS - Sof aktivlarga nisbatan bozor kapitallashuvi|enGene Holdings Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|rapt.com (RAPT) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati JBIO (Aerovate Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ACRS|Kyverna (KYTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Tiziana Life Sciences, Ltd. (TLSA)|Bozor kapitallashuvining balans qiymatiga nisbati CABA|ventyxbio.com - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati THTX (Theratechnologies)|Avalo Therapeutics, Inc. (AVTX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Eledon ELDN|AGEN (Agenus, Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Climb Bio Inc CLYM|Sof aktivlarga nisbatan bozor kapitallashuvi zurabio.com|aTyr Pharma (ATYR) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati adagene.com (ADAG)|Bozor kapitallashuvining balans qiymatiga nisbati IMA (Ikena Oncology)|Shattuck Labs Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Equillium Bio (EQ)|CNTB: Balans qiymatiga nisbatan bozor qiymati|IMUX (immunic-therapeutics.com) - Bozor qiymatining balans qiymatiga nisbati|Atara Bio (ATRA) - Kapitallashuvning sof aktivlarga nisbati|IFRX (InflaRx NV) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati X4 Pharmaceuticals, Inc|Bozor kapitallashuvining balans qiymatiga nisbati ACET (Adicet Bio)|Kapitallashuvning sof aktivlarga nisbati celularity.com (CELU)|INMB: Bozor kapitallashuvining balans qiymatiga nisbati|BRNS - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kezar Life Sciences, Inc - Kapitallashuvning sof aktivlarga nisbati|SAB Biotherapeutics Inc (SABS) - Bozor kapitallashuvining balans qiymatiga nisbati|AKTX - Kapitallashuvning sof aktivlarga nisbati|Enlivex Therapeutics Ltd. (ENLV) - Bozor kapitallashuvining balans qiymatiga multiplikatori|QTTB: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi GeoVax Labs|Bozor kapitallashuvining balans qiymatiga nisbati EDSA (Edesa)|Kapitallashuvning sof aktivlarga nisbati iBio Corporation (IBIO)|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|xtlbio.com - Bozor kapitallashuvining balans qiymatiga nisbati|BOLT - Bozor qiymatining balans qiymatiga nisbati|HCWB: Bozor qiymatining balans qiymatiga nisbati|aptevotherapeutics.com - Bozor qiymatining balans qiymatiga nisbati|AIM (aimimmuno.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc. ADTX|Sof aktivlarga nisbatan bozor kapitallashuvi gribio.com (GRI)|Kapitallashuvning sof aktivlarga nisbati XORTX Therapeutics (XRTX)|Bozor qiymatining balans qiymatiga nisbati HIND (Vyome Holdings Inc.)|Bozor qiymatining balans qiymatiga nisbati Revelation Bio REVB|Bozor qiymatining balans qiymatiga nisbati Indaptus Corp INDP|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|CALI: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati affimed.com (AFMD)|Allakos (ALLK) - Sof aktivlarga nisbatan bozor kapitallashuvi|HOOK - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IGM Bio|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati OCEA (oceanbiomedical.com)|Bozor qiymatining balans qiymatiga nisbati TC BioPharm|Third Harmonic Bio Inc. - Balans qiymatiga nisbatan bozor qiymati